Induction of implantation by aromatase inhibitors in ovariectomized mice.
The ability of aromatase inhibitors to induce implantation in mice was tested in animals in which implantation was delayed by ovariectomy and progesterone treatment. Implantation was consistently induced by 7 mg 4-hydroxyandrostene-3,17-dione (4-OH-A), 7 X 5 mg 1,4,6-androstatriene-3,17-dione (ATD) or 15 mg 4-acetoxyandrostene-3,17-dione, an activity comparable to that of 1 mg testosterone. In intact mice treated with 2 or 10 mg 4-OH-A or ATD/day from Day 2 of pregnancy (Day 1 = vaginal plug), the number and size of implantation sites were not affected. These results may not be necessarily due to inhibitory effects of the compounds on aromatase.
D000733:Androstatrienes / Q000494:pharmacology; D000735:Androstenedione / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D047072:Aromatase Inhibitors; D002369:Castration; D010064:Embryo Implantation / Q000187:drug effects*; D005260:Female; D051379:Mice; D008815:Mice, Inbred Strains; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology
D000733:Androstatrienes; D047072:Aromatase Inhibitors; C011658:androsta-1,4,6-triene-3,17-dione; D013739:Testosterone; D000735:Androstenedione; D011374:Progesterone; C022569:4-acetoxy-4-androstene-3,17-dione; D010088:Oxidoreductases; C014594:formestane